58 Apartments Replace Plan for New WBZ Studios
A Brookline developer is seeking to build 58 housing units on an Allston parcel once envisioned for a new WBZ-TV headquarters.
A Brookline developer is seeking to build 58 housing units on an Allston parcel once envisioned for a new WBZ-TV headquarters.
Takeda Pharmaceutical Co.’s move to its new Kendall Square tower is opening up big new blocks of availability in the Cambridge lab market.
Boston-based Samuels & Associates will operate the Fenway Time Out Market under a licensing agreement, staving off its planned closure this week.
Lab vacancies in Greater Boston hit 34 percent in the fourth quarter despite a pair of big leases in Somerville and Allston.
Boston’s first large-scale food hall is set to end its seven-year run in the Fenway despite kicking off a boom in craft food halls around the region.
Newton-based National Development acquired the Watertown Mall for $100 million, closing the chapter on a potential life science redevelopment.
A Cambridge biotech will relocate to Watertown after terminating its lease and committing to occupy nearly 73,000 square feet at 99 Coolidge Ave.
Alexandria Real Estate Equities is bracing for a double-digit increase in costs on its current development pipeline related to the Trump administration’s tariff policies and inflation.
A former Massachusetts employee stole company secrets and strategies on lab properties, major life science developer Alexandria Real Estate Equities claims in a lawsuit.
A Newton office park that was earlier slated for a life science conversion landed a large office tenant that’s expected to bring 600 employees to the campus.
Alexandria Real Estate Equities sold three Kendall Square life science buildings to its archrival BioMed Realty for $250 million in a transaction between the nation’s two largest lab landlords.
Alexandria bought the huge facility in early 2022 as part of a $341 million, eight-property deal to take advantage of drugmaking demand that never materialized.
Lab developer Alexandria Real Estate Partners will sell the Moderna Technology Center in Norwood to the vaccine manufacturer for approximately $400 million as it continues to divest non-core properties in Greater Boston.
The leading U.S. life science landlord has agreed to sell more properties in Greater Boston for nearly $370 million and recorded an impairment charge of $40.9 million.
A vision to turn West Cambridge into a second Kendall Square is coming apart amid record lab vacancies across the region, as the fundamentals of development look set to shift back in favor of multifamily housing.
The life sciences and lab market across the Boston metro area has been in a state of flux for some time, but a new factors have added extra pressure on landlords and owners.
The nation’s largest life science developer acquired the WBZ-TV studio property in Allston, where a large redevelopment including offices, labs and housing was approved in 2022 but has yet to begin
A site once proposed for lab space was acquired by a Boston-based marketing agency as Alexandria Real Estate Equities scaled back its appetite for development.
Takeda Pharmaceutical Co. inked a 10-year lease extension at its 222,025-square-foot R&D center in Cambridge’s Kendall Square.
A Lawrence buyer snapped up an Andover office building put on the market by Alexandria Real Estate Equities after just over two years of ownership.